Medicine News and Research

RSS

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.

20 Dec 2013

Adults nationwide concerned about use of e-cigarettes by children and teens

Adults nationwide are concerned about the use of e-cigarettes by children and teens, with 44 percent indicating worries that the devices will encourage kids to use tobacco products, according to a new poll from the University of Michigan.

20 Dec 2013

Joint initiative aims to eradicate health disparities among communities of color in the U.S.

The world's first and largest group medical practice and one of the nation's premier volunteer service organizations of professional African American women are joining forces to eradicate health disparities among communities of color in the United States. Mayo Clinic and The Links, Incorporated have established a formal collaboration that aims to develop a more diverse health care workforce.

20 Dec 2013

Five tips to identify individuals who may be vulnerable during holidays

While it is true that suicide rates are actually lower at the holidays compared to other times of the year, the holidays can be a very lonely time for those with nowhere to go and no one to turn to.

20 Dec 2013

Viewpoints: Republicans' 'repeal trap;' 'insufferable' pajama boy; ADHD epidemic; ACLU's campaign against Catholic hospitals

The Journal Gazette of Fort Wayne, Indiana, reports on a fascinating exchange between GOP Rep. Marlin Stutzman and a local meat market owner, Lee Albright, who likes the Affordable Care Act and quizzed the Congressman about the real world implications of the GOP repeal stance (Greg Sargent, 12/18).

20 Dec 2013

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.

20 Dec 2013

Longer looks: A 'biopsy chaperone;' medical errors at assisted living homes; 'wasting money' on multivitamins

At least 80 times in recent years, employees at San Diego County assisted living homes overlooked serious medical issues, gave the wrong medication or otherwise failed to properly care for vulnerable seniors. The problems arose as a result of the unique position held by the care homes, viewed by many families as health-care facilities even though they lack the required levels of training, supervision and oversight. The new cases were examined by U-T Watchdog as part of an ongoing partnership with the CHCF Center for Health Reporting at the University of Southern California (Jeff McDonald, 12/14).

20 Dec 2013

Top cancer centers lack policies to protect cancer patients' fertility

Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults. Yet the leading National Cancer Institute-designated comprehensive cancer centers -- which should be leaders in fertility preservation -- aren't doing an adequate job of helping patients protect their fertility, reports a new Northwestern Medicine- study.

20 Dec 2013

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration to treat epilepsy, with potential to help millions of people worldwide.

20 Dec 2013

People with diabetes at risk of developing diabetic macular edema during their lifetime

Despite recent advances in prevention and treatment of most vision loss attributed to diabetes, a new study shows that fewer than half of Americans with damage to their eyes from diabetes are aware of the link between the disease and visual impairment, and only six in 10 had their eyes fully examined in the year leading up to the study.

20 Dec 2013

Simple tool right in your back pocket may help decrease type 2 diabetes risks

New University of Michigan research says that a simple tool right in your back pocket may help decrease your risk for type 2 diabetes: Text messages on your phone.

20 Dec 2013

Researchers identify molecular link between liver cancer, obesity, alcoholism, and hepatitis

Obesity, alcoholism, and chronic hepatitis all increase the risk of getting liver cancer, which is the third leading cause of cancer death worldwide. Obesity in particular is driving a significant increase in liver cancer in the United States.

20 Dec 2013

New research assesses nanomedicine-based approaches for treating cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.

20 Dec 2013

Researchers discover cancer-killing properties of frankincense in ovarian cancer

Researchers from the University of Leicester have, for the first time, demonstrated the potential of treating ovarian cancer using the Christmas gift frankincense.

20 Dec 2013

African-American women may need to eat fewer calories or burn more to lose weight

African-American women may need to eat fewer calories or burn more than their Caucasian counterparts to lose a comparable amount of weight, according to researchers at the University of Pittsburgh School of Medicine in a study published online today in the International Journal of Obesity.

20 Dec 2013

Most dementia people living at home have multiple unmet health and welfare needs

Most people with dementia who live at home have multiple unmet health and welfare needs, any number of which could jeopardize their ability to remain home for as long as they desire, new Johns Hopkins research suggests.

20 Dec 2013

BCG vaccine highly protective against pulmonary TB: Study

The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.

20 Dec 2013

Takeda to acquire exclusive license to develop Natrogen's Natura-alpha compound

Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.

20 Dec 2013

BeiGene doses first patient in Phase 1 study of BGB-283

BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.

20 Dec 2013

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.

From Baxter International Inc. 20 Dec 2013

Medicine News and Research

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

Adults nationwide concerned about use of e-cigarettes by children and teens

Joint initiative aims to eradicate health disparities among communities of color in the U.S.

Five tips to identify individuals who may be vulnerable during holidays

Viewpoints: Republicans' 'repeal trap;' 'insufferable' pajama boy; ADHD epidemic; ACLU's campaign against Catholic hospitals

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

Longer looks: A 'biopsy chaperone;' medical errors at assisted living homes; 'wasting money' on multivitamins

Top cancer centers lack policies to protect cancer patients' fertility

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

People with diabetes at risk of developing diabetic macular edema during their lifetime

Simple tool right in your back pocket may help decrease type 2 diabetes risks

Researchers identify molecular link between liver cancer, obesity, alcoholism, and hepatitis

New research assesses nanomedicine-based approaches for treating cancer

Researchers discover cancer-killing properties of frankincense in ovarian cancer

African-American women may need to eat fewer calories or burn more to lose weight

Most dementia people living at home have multiple unmet health and welfare needs

BCG vaccine highly protective against pulmonary TB: Study

Takeda to acquire exclusive license to develop Natrogen's Natura-alpha compound

BeiGene doses first patient in Phase 1 study of BGB-283

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News